Skip to main content
Fig. 4 | BMC Medical Genomics

Fig. 4

From: Findings from precision oncology in the clinic: rare, novel variants are a significant contributor to scaling molecular diagnostics

Fig. 4

Longitudinal analysis by analysis group and assay type of mean curated variants/sample using a three-month rolling mean with 95% confidence intervals. (top chart) Hyb-capture somatic solid samples (red) are increasing in the number of new variants requiring curation. (bottom chart) Amplicon assay samples have required less than 0.5 curations each across all analysis groups over that last three years

Back to article page